£3.3M
The investment was led by Whiterock with participation from regional funds and angel backers.
CN
Cumulus Neuroscience
Digital biomarker platform provider for neuroscience clinical trials and patient monitoring.
Belfast, UK—Founded 2015
£9.3MTotal raised
Cumulus Neuroscience develops digital biomarker platforms and dry sensor EEG headsets to advance neuroscience clinical trials and patient care.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Cumulus Neuroscience's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
RC
Ronan Cunningham
CEO
Ronan brings executive and innovation leadership experience, having served as CEO of Cumulus Neuroscience and Director of Innovation at DCU Innovate. He also contributes to the sector as a board member at Neuranics and through independent strategic advisory roles.
LinkedInTS
Tina Sampath
Chief Executive
Tina brings marketing and executive experience across biopharma, diagnostics, and digital health. She serves as chief executive of Cumulus Neuroscience, following commercial and interim leadership roles at the company.
LinkedInInvestors
- £3.3M
- £6.0M
Funding history
£6.0M
The financing round was led by the Dementia Discovery Fund with backing from LifeArc and the UK Future Fund.